An interventional study of Intercostal tube and Video assisted thoracoscope in Second Stage Empyema, sponsored by Sohag University. Not yet recruiting. Per ClinicalTrials.gov, last updated 2024-11-08.
Sponsored by Sohag University · Not applicable, Interventional, and Treatment
The goal of this clinical trial is to compare between outcome of inter-costal tube drainage and video assisted thoracoscopic surgery in management of patients with second stage empyema.
It compares the outcome of both interventions in hospital stay, cost, wether need of decortication later on or not.
38 studies on the registry are indexed under Empyema; 11 are open to participants now.
This study's planned enrollment of 40 is below the median of 92 across 28 interventional studies indexed under Empyema.
Browse Empyema studies →Sohag University is the lead sponsor of 1,230 studies on the registry; 636 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Immunosuppression
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Intercostal tube as a primary intervention for treatment of second stage empyema
Procedure: Intercostal tube
Video assisted thoracoscopic evacuation as a primary intervention for treatment of nd stage empyema
Procedure: Video assisted thoracoscope
Intercostal tube drainage as a first management of second stage empyema
Also known as: Chest tube
Video assisted thoracoscopic surgery as a first management for second stage empyema
Also known as: VATS
the length of hospital stay
Comparison between both intercostal tube drainage and video assisted thoracoscopic surgery in management of patients with second stage empyema, we will compare the length of hospital stay of each group of patients
Time frame: From enrollment to 4 weeks
cost of treatment of the patients' in each group
Comparison between both intercostal tube drainage and video assisted thoracoscopic surgery in management of patients with second stage empyema, we will compare cost of treatment of the patients' in each group
Time frame: 4 weeks
number of participants with needs of decortication later on or not, assessed by the chest X-ray and CT chest.
Comparison between both intercostal tube drainage and video assisted thoracoscopic surgery in management of patients with second stage empyema, we will compare with the chest X-ray and CT chest if there is residual empyema and whether the patients will need decortication later on or not
Time frame: 4 weeks
No study locations are listed for this record.
Plan to share: Undecided
Start is estimated for Nov 2024; primary completion for Jul 2025, 8 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.